The board of Marksans Pharma has decided to enter into share purchase agreement with Hale Group, U.K. for acquiring its entire share capital along with its subsidiary company Bell, Sons & Co. (Druggists) and authority to Mark Saldanha, managing director to execute the same. The above acquisition shall be through companies 100% subsidiary, Marksans Pharma U.K.